Ftse Mib
34.229,69
0,85%
DAX
18.095,12
0,96%
S&P 500
5.093,49
0,89%
NASDAQ Composite
15.822,13
1,35%
Bitcoin
64.332,74
-0,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni Regno Unito LSE Immunovia Ab (publ) (0G8X) Immunovia Ab (publ) (0G8X) Notizie

Immunovia Ab (publ)

0G8X
191,40
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: SEK

Ultime notizie

Data Ora Fonte Titolo
04/1/202416:59PRNUSImmunovia announces financial calendar for financial year..
04/1/202416:58PRNUSImmunovia announces financial calendar for financial year..
21/11/202311:40PRNUSBulletin from the extraordinary general meeting in Immunovia..
21/11/202311:38PRNUSBulletin from the extraordinary general meeting in Immunovia..
09/11/202309:03PRNUSImmunovia Publishes Interim Report for January-September..
09/11/202308:59PRNUSImmunovia Publishes Interim Report for January-September..
07/11/202316:14PRNUSImmunovia successfully completes discovery phase of..
07/11/202316:12PRNUSImmunovia successfully completes discovery phase of..
02/11/202311:02PRNUSInvitation to Immunovia's Q3 presentation
02/11/202311:00PRNUSInvitation to Immunovia's Q3 presentation
27/10/202309:06PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
27/10/202309:03PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
03/10/202311:01PRNUSNomination Committee appointed for Immunovia AB (Publ)
03/10/202310:56PRNUSNomination Committee appointed for Immunovia AB (Publ)
30/8/202312:30PRNUSImmunovia Publishes Interim Report for January-June 2023
30/8/202308:56PRNUSImmunovia Publishes Interim Report for January-June 2023
23/8/202320:08PRNUSInvitation to Immunovia's Q2 presentation
23/8/202320:06PRNUSInvitation to Immunovia's Q2 presentation
19/7/202318:47PRNUSImmunovia announces updated financial calendar
12/7/202309:15PRNUSImmunovia to Significantly Restructure to Focus Resources on..
12/7/202309:12PRNUSImmunovia to Significantly Restructure to Focus Resources on..
09/6/202310:19PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
09/6/202310:11PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
31/5/202312:16PRNUSChange in number of shares and votes in Immunovia AB (publ)
31/5/202312:13PRNUSChange in number of shares and votes in Immunovia AB (publ)
26/5/202313:43PRNUSBulletin from the Annual General Meeting in Immunovia AB
26/5/202313:41PRNUSBulletin from the Annual General Meeting in Immunovia AB
23/5/202309:03PRNUSImmunovia Publishes Interim Report for January-March 2023
23/5/202309:00PRNUSImmunovia Publishes Interim Report for January-March 2023
22/5/202318:55PRNUSChanges to the Nomination Committee's proposal to the Annual..
22/5/202318:51PRNUSChanges to the Nomination Committee's proposal to the Annual..
17/5/202310:43PRNUSInvitation to Immunovia's Q1 presentation
17/5/202310:41PRNUSInvitation to Immunovia's Q1 presentation
06/5/202313:40PRNUSThe board member Philipp von Hugo resigns from Immunovia's..
30/4/202312:17PRNUSImmunovia AB appoints new CEO
30/4/202312:15PRNUSImmunovia AB appoints new CEO
Apertura: Min: Max:
Chiusura: 191,40

La tua Cronologia

LSE
0G8X
Immunovia Ab (publ)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network